Adamax
Minimal evidence — Very little published dataWhat it is
A proprietary nootropic peptide (marketed as a Semax-related analogue). Independent evidence is minimal; treat as unverified.
Adamax is a proprietary nootropic peptide marketed as a Semax-related analogue. Independent evidence is minimal; treat its composition and claims as unverified.
Research context
Studied in relation to:
- Cognition research (supplier-defined)
Points in its favour in the literature:
- Marketed as a potent nootropic
Caveats and unknowns:
- Little independent evidence
- Composition/claims supplier-defined
- Unlicensed
Handling & reference data
Route in published researchIntranasal or subcutaneous, per supplier.
Published clinical / research context (not instructions)Supplier-defined; not independently established.
Storage (lyophilised)Lyophilised (freeze-dried) powder: refrigerate at 2–8 °C short-term, or freeze at −20 °C or below for long-term storage. Keep sealed and out of light.
Reconstituted solutionOnce reconstituted: keep refrigerated (2–8 °C), protect from light, do not freeze. With bacteriostatic water, commonly used within ~4 weeks; with plain sterile water, within ~24–48 h.
Worked reconstitution example (arithmetic only)e.g. 5 mg vial + 2 mL → 2.5 mg/mL.
Available research formats
| Strength | SKU |
|---|---|
| 5mg | ADA5 |
| 10mg | ADA10 |
Current pricing (THB with USD/GBP conversion) is shown live in the catalogue, which also has a transparent U-100 reconstitution calculator.